Publication: 281

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
      QxMD      Google Scholar   
Citation:
Neuro Oncol vol 14 (2) 215-221
Year:
2012
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
1
Parents:
638  
Children:
None
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
 
Grants:
R01 CA 154348, U10 CA 25224  
Corr. Author:
 
Authors:
                         
Networks:
 
Study
NCCTG-N0779
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
bortezomib, phase II trial, recurrent glioblastoma, vorinostat